Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some Prices
Stock Movers3 Helmi

Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some Prices

Today's biggest winners and losers in the stock market.


On this episode of Stock Movers:
- Pfizer (PFE) reported revenue for the fourth quarter that beat the average analyst estimate.
- Merck (MRK) forecast 2026 sales and profit that missed Wall Street’s expectations as continued challenges with its HPV vaccine Gardasil, which may remain off the market in China this year, overshadowed growth from newer drugs. Full-year sales will be $65.5 billion to $67 billion, Merck said Tuesday, below the average estimate from analysts. The company expects adjusted earnings of as much as $5.15 a share. The stock fell as much as 3.2% in pre-market trading.
- Snacks and beverage company PepsiCo (PEP) reported better-than-expected fourth-quarter profit, buoyed by strong international demand, and announced a $10 billion share buyback.New York-based PepsiCo, which owns brands such as Lay’s and Gatorade, posted earnings per share of $2.26, slightly ahead of Wall Street estimates.

See omnystudio.com/listener for privacy information.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(2255)

JetBlue Soars, Meta Gains, Arm Rises

JetBlue Soars, Meta Gains, Arm Rises

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: JetBlue Airways (JBLU) is considering the option of selling itself to a competitor, Semafor reported, citing pe...

25 Maalis 5min

KB Home Drops, Sarepta Jumps, ARM Gains on Plans to Sell Its Own Chips

KB Home Drops, Sarepta Jumps, ARM Gains on Plans to Sell Its Own Chips

On this episode of Stock Movers: - KB Home (KBH) shares fell after the single-family home builder reported forecast deliveries for the second quarter that missed the average analyst estimate. - Sarept...

25 Maalis 2min

ARM Rises, Chewy Gains, Echostar Up on Report SpaceX to File for IPO Soon as This Week

ARM Rises, Chewy Gains, Echostar Up on Report SpaceX to File for IPO Soon as This Week

On this episode of Stock Movers: - ARM (ARM) shares rise after news it will sell its own chips for the first time, with Meta Platforms Inc. as the first major customer, and expects to generate about $...

25 Maalis 3min

Merck to Buy Terns; Pentagon Inks Deals to Boost Production; Chewy Shares Gain

Merck to Buy Terns; Pentagon Inks Deals to Boost Production; Chewy Shares Gain

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Merck (MRK) agreed to buy Terns Pharmaceuticals Inc. for $6.7 billion, giving the multinational company acces...

25 Maalis 4min

Merck to Buy Terns Pharmaceuticals; Arm to Sell Its Own Chips; Braze Shares Climb

Merck to Buy Terns Pharmaceuticals; Arm to Sell Its Own Chips; Braze Shares Climb

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Merck & Co (MRK) to buy Terns Pharmaceuticals (TERN) for $53/share in cash for an approximate equity value of $...

25 Maalis 4min

KB Homes Down, Arm to Sell Its Own Chips, ImmunityBio Plunges

KB Homes Down, Arm to Sell Its Own Chips, ImmunityBio Plunges

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- KB Home (KBH) shares are down 5% in postmarket trading Tuesday after the single-family home builder reported fo...

24 Maalis 3min

Closing Bell: Coal Stocks Rise, Circle Internet Falls, Uber Slides

Closing Bell: Coal Stocks Rise, Circle Internet Falls, Uber Slides

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- US coal stocks climb on Tuesday as the Iran war continues and the tightened supply of liquefied natural gas is ...

24 Maalis 4min

Concentrix Falls, Jefferies Mixed, ImmunityBio Down as FDA Issues Warning Letter on Cancer Claims

Concentrix Falls, Jefferies Mixed, ImmunityBio Down as FDA Issues Warning Letter on Cancer Claims

On this episode of Stock Movers: - Concentrix (CNXC) shares fall as the software company’s second-quarter forecast was weaker than expected. Vital Knowledge also notes “a modest shortfall on FQ1 EPS,...

24 Maalis 2min

Suosittua kategoriassa Politiikka ja uutiset

uutiscast
aikalisa
politiikan-puskaradio
viisupodi
ootsa-kuullut-tasta-2
rss-ootsa-kuullut-tasta
tervo-halme
rss-vaalirankkurit-podcast
rss-asiastudio
the-ulkopolitist
rss-podme-livebox
rss-pinnalla
otetaan-yhdet
et-sa-noin-voi-sanoo-esittaa
rss-ulkopoditiikkaa
aihe
rikosmyytit
yksilla-raahessa-podcast
rss-hyvaa-huomenta-bryssel
rss-raha-talous-ja-politiikka